Cassandra Barker, CNP - Closed

Dr. Ankit Mangla is a medical oncologist at University Hospitals Seidman Cancer Center, specializing in the treatment of melanoma and rare tumors, including Merkel cell cancer and soft tissue sarcoma. He is dedicated to developing patient-centric treatment plans that minimize toxicity while maximizing efficacy, and serves as the Co-Director of the Sarcoma and Cutaneous Oncology Team. With a robust background in clinical research, Dr. Mangla has authored numerous papers in prestigious medical journals and participates in several oncology consortia focused on drug development. His commitment to advancing cancer treatment is reflected in his role as a principal investigator for multiple clinical trials aimed at improving outcomes for patients with melanoma and soft tissue sarcomas. Generated from the website

Lauren Henke, MD is a radiation oncology specialist located in Avon, OH. With expertise in adaptive radiotherapy and clinical trial design, Dr. Henke is dedicated to providing high-quality care to patients with colorectal cancer, anal cancer, and hepatobiliary cancer, among others. Fluent in English and Spanish, Dr. Henke is affiliated with several medical centers, including UH Cleveland Medical Center and SCC Seidman Cancer Center. University Hospitals, where Dr. Henke practices, is committed to transparency in their interactions with industry partners and strives to provide patients with the best possible care. Their practitioners disclose any ownership or intellectual property rights related to commercialized products and report any payments from companies they interact with. With a focus on improving quality of care and clinical outcomes, University Hospitals values patient education and encourages open discussions about industry relationships and their potential impact on medical care.Generated from the website

Michelle Porter, PA-C, is a board-certified physician assistant at University Hospitals Seidman Cancer Center. As an advanced practice provider in medical breast oncology, Michelle collaborates with oncologists and other specialists to develop and implement treatment plans for patients with breast cancer. She is also highly involved in the breast cancer survivorship program and strives to integrate the latest clinical innovations into each treatment plan to improve patient outcomes.